All of us here at Thalocan Research Innovations applaud the work of The American Academy of Dermatology in designating November as National Healthy Skin Month. It is indeed an awareness month for all. At TRI we are proud to continue our goal to revolutionize the assessment of dermatological diseases with the latest technology, designed to enhance every…
At SHSA 2025 in Nashville this past weekend, one of the primary topics discussed at our booth was the urgent needed for standardizing assessment for Hidradenitis Suppurativa. Being aware of the various ways that raters are CURRENTLY mapping lesions and how that process can be improved and standardized provided us with the roadmap we needed…
Eric Zudak, CEO of Thalocan Research Innovations, discusses Thalocan’s role in helping to address unmet needs in the immunodermatology area. With many, if not most inflammatory skin diseases being more common in Skin of Color than in lighter pigmented skin – Thalocan is proud to provide cutting edge technology, training and tools for more accurate scientific…
We are very excited to share our UPDATED comprehensive VASI training course! Authored by Dr. Iltefat Hamzavi, this enhanced training was designed by Thalocan Research Innovations to improve efficiency in clinical trial training management and support consistent severity assessment in #vitiligostudies. Please contact licensing@thalocan.com for details.
